| To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer (NCT02029209) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2013-12-01 |
| Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-angiotensin-aldosterone System (NCT02010905) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2013-12-01 |
| Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma (NCT01980628) | Pharmacyclics LLC. | 2013-12-01 |
| Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse (NCT01995578) | Memorial Sloan Kettering Cancer Center | 2013-12-01 |
| Propranolol in Severely Burned Children (NCT01957449) | The University of Texas Medical Branch, Galveston | 2013-12-01 |
| Study of Ibrutinib in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma (NCT01980654) | Pharmacyclics LLC. | 2013-12-01 |
| A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT (NCT02010203) | Heat Biologics | 2013-12-01 |
| Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients (NCT02093195) | Air Force Military Medical University, China | 2013-12-01 |
| Cyclosporine A in Patients With Small Diameter Abdominal Aortic Aneurysms (NCT02225756) | Assistance Publique - Hôpitaux de Paris | 2013-12-01 |
| BiPAP-Vapotherm RCT (NCT01518140) | M.D. Anderson Cancer Center | 2013-12-01 |
| Effect and Safety Study of Atorvastatin to Treat Chronic Subdural Hematoma (NCT02024373) | Oriental Neurosurgery Evidence-Based-Study Team | 2013-12-01 |
| Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation (NCT01882374) | Tarix Pharmaceuticals | 2013-12-01 |
| Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer (NCT01349088) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-12-01 |
| Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-) (NCT02006043) | Li Zhang | 2013-12-01 |
| Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting (NCT01778348) | University of Cambridge | 2013-12-01 |
| Study of orBec® as Monotherapy in the Treatment of Patients With Upper GI Symptoms Caused by Chronic Graft Versus Host Disease (GVHD) (NCT01925950) | Soligenix | 2013-12-01 |
| tDCS in Poststroke on Upper Limb Rehabilitation (NCT02166619) | Universidade Federal de Pernambuco | 2013-12-01 |
| A Pharmacokinetic Study of Sevoflurane Inhalation in Burn ICU Patients (NCT02048683) | University Hospital, Clermont-Ferrand | 2013-12-01 |
| Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis (NCT01958944) | Beyond Air Inc. | 2013-12-01 |
| Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant (NCT02038153) | Albert Einstein College of Medicine | 2013-12-01 |
| Evaluation of 3 Different Doses of IV Busulfan (NCT01985061) | Institut Paoli-Calmettes | 2013-12-01 |
| Transurethral Myoblast Injection for Urinary Incontinence in Children With Bladder Exstrophy (NCT02075216) | Al-Azhar University | 2013-12-01 |
| Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia (NCT01677949) | Masonic Cancer Center, University of Minnesota | 2013-12-01 |
| Edoxaban for TIA and Acute Minor Stroke (NCT02221102) | Xijing Hospital | 2013-12-01 |
| The Effect of Vitamin C on Growth Hormone Secretion (NCT01537094) | Massachusetts General Hospital | 2013-12-01 |
| 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy (NCT01991977) | Mayo Clinic | 2013-12-01 |
| Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression (NCT01998061) | Zhejiang University | 2013-12-01 |
| Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy (NCT02032563) | Jules Bordet Institute | 2013-12-01 |
| IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL) (NCT02028039) | M.D. Anderson Cancer Center | 2013-12-01 |
| Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis (NCT02035514) | Germans Trias i Pujol Hospital | 2013-12-01 |
| A Study to Explore the Efficacy of TRV027 in Patients Hospitalized for Acute Decompensated Heart Failure (NCT01966601) | Trevena Inc. | 2013-12-01 |
| Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA (NCT01993641) | Helsinn Healthcare SA | 2013-12-01 |
| Cerebral Oxygenation to Guide Supplemental Oxygen (NCT02017691) | Medical University of Graz | 2013-12-01 |
| AAV1-CMV-Serca2a GENe Therapy Trial in Heart Failure (NCT01966887) | Assistance Publique - Hôpitaux de Paris | 2013-12-01 |
| A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria (NCT01987947) | Genentech, Inc. | 2013-12-01 |
| Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia (NCT01969799) | Cardeas Pharma | 2013-12-01 |
| Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior (NCT01588951) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-12-01 |
| Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC) (NCT02019979) | Beth Israel Medical Center | 2013-12-01 |
| Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma (NCT01808599) | International Extranodal Lymphoma Study Group (IELSG) | 2013-12-01 |
| A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis (NCT01988961) | Janssen Research & Development, LLC | 2013-12-01 |
| NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG (NCT02027831) | Jules Bordet Institute | 2013-12-01 |
| Open-Label Safety Study of Telaprevir and Sofosbuvir in Chronic Hepatitis C Genotype 1 (NCT01994486) | University of Florida | 2013-12-01 |
| A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence (NCT01272258) | CytoDyn, Inc. | 2013-12-01 |
| Vitamin D Supplementation in Cirrhotic Patients (NCT02009748) | Medical University of Graz | 2013-12-01 |
| A Study of RO6811135 in Patients With Type 2 Diabetes Who Are Inadequately Controlled With Metformin (NCT01951183) | Hoffmann-La Roche | 2013-12-01 |
| Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults (NCT02030301) | Vical | 2013-12-01 |
| Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC (NCT01897610) | GC Cell Corporation | 2013-12-01 |
| Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) (NCT01998633) | Medical College of Wisconsin | 2013-12-01 |
| Evaluation of the Immediate Effect of Acupuncture on the Upper Trapezius Muscle in Patients With Nonspecific Neck Pain. (NCT01984021) | University of Nove de Julho | 2013-12-01 |
| EWOC-1 Trial: Carboplatin +/- Paclitaxel in Vulnerable Elderly Patients With Stage III-IV Advanced Ovarian Cancer (NCT02001272) | Hospices Civils de Lyon | 2013-12-01 |
| Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180) (NCT01992536) | Novartis Vaccines | 2013-12-01 |
| Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma (NCT01962792) | Pharmacyclics LLC. | 2013-12-01 |
| Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis. (NCT02096315) | Polyphor Ltd. | 2013-12-01 |
| A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer (NCT02013453) | University of Michigan Rogel Cancer Center | 2013-12-01 |
| Impact of Nutritional Intervention in Indian Female Cancer Cachexia Patients (NCT02350855) | University of Westminster | 2013-12-01 |
| Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying (NCT01910194) | Profil Institut für Stoffwechselforschung GmbH | 2013-12-01 |
| ACZ885 for the Treatment of Abdominal Aortic Aneurysm (NCT02007252) | Novartis Pharmaceuticals | 2013-12-01 |
| Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage (NCT01787123) | Kwong Wah Hospital | 2013-12-01 |
| Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson's Disease (NCT01968460) | Pharma Two B Ltd. | 2013-12-01 |
| The Role of Vasopressin in the Social Deficits of Autism (NCT01962870) | Stanford University | 2013-12-01 |
| Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects (NCT02016560) | Avid Radiopharmaceuticals | 2013-12-01 |
| Biomarkers of Irritant-Induced and Allergic Asthma (NCT02740543) | NYU Langone Health | 2013-12-01 |
| Ursodeoxycholic Acid as Treatment for Polycystic Liver Disease (NCT02021110) | Radboud University Medical Center | 2013-12-01 |
| The Use of Zoledronic Acid to Complex Regional Pain Syndrome (NCT01788176) | University of Sao Paulo General Hospital | 2013-12-01 |
| Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study (NCT01973920) | Oshadi Drug Administration | 2013-12-01 |
| Phase 2 Study of Ipilimumab in Japanese Advanced Melanoma Patients (NCT01990859) | Bristol-Myers Squibb | 2013-12-01 |
| Esmolol Effects on Heart and Inflammation in Septic Shock (NCT02068287) | Central Hospital, Nancy, France | 2013-12-01 |
| Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission (NCT01982487) | Roswell Park Cancer Institute | 2013-12-01 |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors (NCT02001623) | Seagen Inc. | 2013-11-30 |
| A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis (NCT01999582) | Celgene | 2013-11-30 |
| Study to Assess the Safety of BAY1067197 in Stable Heart Failure Patients on Standard Therapy Including ß-blocker (NCT01945606) | Bayer | 2013-11-29 |
| A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma (NCT01992653) | Genentech, Inc. | 2013-11-29 |
| Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED) (NCT01951625) | Bayer | 2013-11-29 |
| Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism (NCT02001051) | National Cancer Institute (NCI) | 2013-11-27 |
| Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation Therapy (NCT01898130) | Northwestern University | 2013-11-27 |
| Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia (NCT01976182) | Rennes University Hospital | 2013-11-26 |
| Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions (NCT03603106) | Guerbet | 2013-11-25 |
| A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model (NCT01980966) | Genentech, Inc. | 2013-11-25 |
| A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL (NCT01874288) | Alopexx Oncology, LLC | 2013-11-25 |
| Cognitive Behaviour Therapy for Voices and Dissociation (NCT04990414) | Greater Manchester Mental Health NHS Foundation Trust | 2013-11-24 |
| Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC) (NCT02404935) | UNICANCER | 2013-11-22 |
| MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients (NCT01959165) | AstraZeneca | 2013-11-21 |
| Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma (NCT01979523) | National Cancer Institute (NCI) | 2013-11-21 |
| Sunshine 2 Study for Women With Diabetes (NCT01904032) | Loyola University | 2013-11-21 |
| Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS) (NCT01786603) | Richard Barohn, MD | 2013-11-21 |
| Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) (NCT01946880) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-20 |
| A Study to Evaluate the Efficacy and Safety of a Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seronegative Kidney Transplant Recipients Receiving an Organ From a CMV-Seropositive Donor (NCT01974206) | Astellas Pharma Global Development, Inc. | 2013-11-20 |
| Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors (NCT01927341) | Pfizer | 2013-11-19 |
| A NEW MECHANICAL DECONTAMINATION METHOD IN PERI-IMPLANTITIS, TI-BRUSH, A RANDOMIZED CONTROLLED CLINICAL TRIAL (NCT03512730) | Universitat Internacional de Catalunya | 2013-11-19 |
| A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL (NCT02055820) | Hoffmann-La Roche | 2013-11-17 |
| Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma (NCT01965119) | Samsung Medical Center | 2013-11-15 |
| A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis (NCT01959282) | Janssen Research & Development, LLC | 2013-11-15 |
| Safety and Efficacy of Resticutis Compared to Platelet-Poor Plasma for Treating Diabetic Foot Ulcers (NCT02989961) | Hanan Jafar | 2013-11-15 |
| A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal Cancer (NCT01925274) | Pfizer | 2013-11-15 |
| Phase II Biomarker Study Comparing the Combination of BRAF Inhibitor Dabrafenib With MEK Inhibitor Trametinib Versus the Combination After Monotherapy With Dabrafenib or Trametinib (NCT02314143) | GlaxoSmithKline | 2013-11-13 |
| Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma (NCT01979536) | National Cancer Institute (NCI) | 2013-11-13 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia (NCT01995838) | Eisai Inc. | 2013-11-13 |
| Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT01892371) | M.D. Anderson Cancer Center | 2013-11-12 |
| Nitrous Oxide Analgesia Vaso-occlusive Crisis (NCT01891812) | Columbia University | 2013-11-12 |
| Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL (NCT01754857) | University of Wisconsin, Madison | 2013-11-12 |